ADAMTS-13 deficiency: Can it cause chronic renal failure?

Nephrology Dialysis Transplantation

Volumn 26, Issue 2, 2011, Pages 742-744

  Bramham, Kate ^a   Hilton, Rachel ^b   Horsfield, Catherine ^b   McDonald, Vickie ^c   Camilleri, Raymond ^c   Hunt, Beverley J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ADAMTS 13 deficiency; chronic kidney disease; thrombotic thrombocytopaenic purpura

Indexed keywords

CD61 ANTIGEN; COMPLEMENT FACTOR H; CREATININE; D DIMER; EPIDERMAL GROWTH FACTOR RECEPTOR; ERYTHROPOIETIN; HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME RELEASE; ERYTHROCYTE; FEMALE; GASTRECTOMY; GASTROINTESTINAL HEMORRHAGE; GENOTYPE; HUMAN; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE DISORDER; LIVER CIRRHOSIS; MACROCYTIC ANEMIA; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE DEFICIENCY;

ADAM PROTEINS; BIOPSY; FATAL OUTCOME; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79551473188     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq644     Document Type: Article

References (9)

1. Dong JF, Moake JL, Nolasco L et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002; 100: 4033-4039
2. Furlan M, Robles R, Galbusera M et al. von Willebrand factorcleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-1584
3. Kokame K, Matsumoto M, Soejima K et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci USA 2002; 99: 11902-11907
4. Sarode R. Atypical presentations of thrombotic thrombocytopenic purpura: a review. J Clin Apher 2009; 24: 47-52
5. Sarode R, Gottschall JL, Aster RH et al. Thrombotic thrombocytopenic purpura: early and late responders. Am J Hematol 1997; 54: 102-107
6. Noris M, Bucchioni S, Galbusera M et al. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. J Am Soc Nephrol 2005; 16: 1177-1183
7. Manea M, Kristoffersson A, Schneppenheim R et al. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol 2007; 138: 651-662
8. Plaimauer B, Fuhrmann J, Mohr G et al. Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation. Blood 2006; 107: 118-125
9. Antoine G, Zimmermann K, Plaimauer B et al. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. Br J Haematol 2003; 120: 821-824